Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Stocks Mixed, Credit Markets Under The Pressure Of Rating Cuts

Published 31/03/2020, 08:04
Updated 31/08/2022, 17:00

The US stock indices extended their advanced for the fourth session over five, recording gains past 3% on Monday, amid healthcare stocks rallied on hopes that a vaccine could curtail the spread of the coronavirus and signal the end of the containment measures that have catastrophic implications for the global economy.

Technology stocks were among the best performers with solid gains in Microsoft (NASDAQ:MSFT) (+7%), Intel (NASDAQ:INTC) (+5.96%) and Apple (NASDAQ:AAPL) (+2.85%) shares. Boeing (NYSE:BA) lost another 6% as US Air Forces announced additional deficiencies in the aerial fuel system of a plane built by the company.

The Chinese manufacturing PMI improved to 52 in March, confirming that the activity picked up following weeks of drastic slowdown due to the coronavirus outbreak. That has been a relief for investors globally.

WTI crude recovered 5% to $22 a barrel, but the market is flooded with oil that no one needs right now. A joint action from oil producer countries to lower production could encourage a certain recovery in oil prices. But any supply-side intervention should be sizeable to match the historical decline in demand, with an estimated 5 million barrels decline in daily oil demand only due to grounded planes globally.

Most Asian indices advanced but gains remained timid. Stocks in Hong King and Shanghai gained 0.28% and 0.12%, while Nikkei slid 0.89% and the ASX 200 gave back 2.02% after yesterday’s 7% on stimulus measures.

European futures hint at a mixed open on Tuesday. The FTSE 100 is expected to open on a negative note, while Eurostoxx futures point at a flat start. News that the coronavirus outbreak could be approaching its peak in Europe should curtail the selling pressure.

The White House, on the other hand, is discussing additional fiscal aid measures worth $600 billion, on top of the historical $2 trillion rescue package just signed a couple of days ago.

Huge amount of helicopter money sprayed on economies to put a floor under the growth slowdown will have long-term implications for debt levels, not only in the US but everywhere in the world.

Now, many of us are wondering whether the governments can extend their debt ad infinitum. The answer is tricky. The US is better positioned compared to most countries for doing so, given that the US government bonds are considered as the ultimate safe haven and the activity on US treasuries prove that the appetite for the US sovereigns remain solid even with the colossal new debt adding to the countries already high level of debt. The US 10-year yield remains a touch below 0.70%, near historically low levels.

But not all countries are under lucky stars. In fact, the rating agencies have already started downgrading countries’ and companies’ credit ratings last week. The UK saw its credit rating lowered at AA- at Fitch and South Africa was cut to junk at Moody’s.

General Electric (NYSE:GE), British Airways and Lufthansa are among companies who saw their credit ratings slashed due to coronavirus-led damages.

Lower credit ratings have a direct impact on governments’ and companies’ ability to contract debt. Because they are considered riskier, the cost of issuing debt for countries and companies with lower credit ratings is more costly. The lower the rating, the costlier the funding by debt. On top, the collateral value of lower grade debt is lessened, which is a major let down for investors as they must decrease the total amount invested if they hold riskier bonds on their portfolios.

In the FX markets, the US dollar index retreated below the 100 mark as stocks gained globally, but the increased anxiety in the credit markets should continue giving some support to the greenback.

The EURUSD slipped below the 1.10 mark and is poised to extend losses as the preliminary inflation read should confirm a decline to 0.8% y-o-y in March from 1.2% printed a month earlier. German import prices fell 0.9% m-o-m in February and worse is yet to come. Eroding inflation could revive the European Central Bank (ECB) doves. Offers are eyed below the 200-day moving average, 1.1053.

Sterling remains offered below 1.25 against the greenback. The UK’s fourth quarter growth figures showed no surprise. The British economy stagnated last quarter, and recession is knocking on the door amid the coronavirus outbreak will further hit the British economy that has been already wrecked by Brexit uncertainties.

Latest comments

Madam, advise the retail traders...  buy the stocks and indices for the future of human....as economy has been damaged due to covid 2019...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.